Barr Pharmaceuticals on Friday announced that FDA has approved its form to sell a generic version of Bayer Schering's oral contraceptive Yasmin in the U.S., Reuters reports (Reuters, 5/9).In March, a federal court in New Jersey invalidated Bayer's patent on Yasmin, ruling in favor of a challenge filed by Barr (Daily Women's Health Policy Report, 3/5). Bayer has appealed the ruling to the U.

More: - Read More